603718.SS

Shanghai Hile Bio-Technology Co., Ltd. [603718.SS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

603718.SS Stock Summary

The Moving Average Convergence Divergence (MACD) for 603718.SS recently turned positive (within last 10 days).

Top 10 Correlated Stocks

603718.SS

In the News

603718.SS Financial details

Company Rating

Market Cap

5.59B

Income

119.19M

Revenue

231.19M

Book val./share

Cash/share

Dividend

0.06

Dividend %

0.58%

Employees

491

Optionable

Shortable

Yes

Earnings

30 Apr 2024

P/E

55.66

Forward P/E

PEG

4.89

P/S

28.03

P/B

5.35

P/C

P/FCF

110.26

Quick Ratio

1.33

Current Ratio

1.59

Debt / Equity

LT Debt / Equity

EPS (TTM)

0.18

EPS next Y

EPS next Q

EPS this Y

127.27%

EPS next Y

EPS next 5Y

EPS last 5Y

44.65%

Revenue last 5Y

3.34%

Revenue Q/Q

33.63%

EPS Q/Q

-122.62%

SMA20

4.08%

SMA50

-0.56%

SMA100

0.42%

Inst Own

Inst Trans

ROA

ROE

10%

ROC

0.05%

Gross Margin

51%

Oper. Margin

28%

Profit Margin

49%

Payout

33%

Shs Outstand

Shs Float

Target Price

52W Range

6.0-11.87

52W High

-33.45%

52W Low

+22%

RSI

59.96

Rel Volume

1.22

Avg Volume

6.67M

Volume

8.12M

Perf Week

4.42%

Perf Month

5.48%

Perf Quarter

-9.29%

Perf Half Y

-9.63%

Beta

1.047

Volatility

0.1%, 0.15%

Prev Close

0.41%

Price

7.32

Change

0.41%

603718.SS Financial Performance

603718.SS Dividend History

603718.SS Frequently Asked Questions

What is Shanghai Hile Bio-Technology Co., Ltd. stock symbol ?

Shanghai Hile Bio-Technology Co., Ltd. is a CN stock and trading under the symbol 603718.SS

What is Shanghai Hile Bio-Technology Co., Ltd. stock quote today ?

Shanghai Hile Bio-Technology Co., Ltd. stock price is $7.32 today.

Is Shanghai Hile Bio-Technology Co., Ltd. stock public?

Yes, Shanghai Hile Bio-Technology Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 6.67M
Market Capitalization 5.59B
Employee 491
CEO Mr. Xiao Chen
Headquarters Shanghai,CN
IPO Date 2015-05-15
Website https://www.hile-bio.com

Shanghai Hile Bio-Technology Co., Ltd. researches, develops, produces, and sells veterinary biological products for livestock and poultry in China. The company offers swine fever live vaccines; trivalent inactivated vaccines for piglets; inactivated vaccine for streptococcus suis; pseudorabies live vaccines; inactivated oil emulsion vaccine of porcine parvovirus disease; pathogenic porcine reproductive and respiratory syndrome live vaccines; transmissible gastroenteritis, porcine epidemic diarrhea, and porcine rotavirus triple live vaccines; porcine reproductive and respiratory syndrome live vaccines; swine transmissible gastroenteritis and swine epidemic diarrhea combined inactivated vaccines; porcine circovirus type 2 inactivated vaccines; and swine Japanese encephalitis live vaccines. It also provides chicken infectious bursal disease live vaccines; inactivated avian infectious rhinitis vaccines; newcastle disease and avian influenza combined inactivated vaccines; newcastle disease, infectious bronchitis, egg drop syndrome, and avian influenza quadruple inactivated vaccines; avian influenza inactivated vaccines; newcastle disease, infectious bronchitis, and avian influenza triple inactivated vaccines; avian infectious bronchitis live vaccines; avian newcastle disease and avian infectious bronchitis combined live vaccines; newcastle disease low virulent live vaccines; Marek's disease turkey herpes virus live vaccines; and fowlpox live vaccines. The company was founded in 1981 and is based in Shanghai, China.